|
|
 |
|
Viewing report
|
|
|
|
Oryzon Genomics - Product Pipeline Analysis
GlobalData, Oct 2011, Pages: 26
Oryzon Genomics - Product Pipeline Analysis
Summary
Oryzon Genomics (Oryzon) is a privately held biotechnology company, specialized in new biomarkers and therapeutic targets in oncology and neurodegenerative diseases. The company's technology platform includes libraries of licensed RNAi that allow the validation of therapeutic targets and test the potential therapeutic use of a given pharmacological approach. Its technology platform integrates the genomics, proteomics and bioinformatics divisions. The company developed a proprietary software for the design of high-specific probes and for the processing and interpretation of the data results.
This report is a source for data, analysis and actionable intelligence on the Oryzon Genomics portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Customers who bought this item also bought
Protagen AG - Product Pipeline Analysis
Pacific Edge Limited (PEB) - Product Pipeline Analysis
Mitomics Inc. - Product Pipeline Analysis
Oxford Gene Technology - Product Pipeline Analysis
AltheaDx, Inc. - Product Pipeline Analysis
DiagnoCure Inc. (CUR) - Product Pipeline Analysis
Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis
Neogenix Oncology, Inc. - Product Pipeline Analysis
Biomoda, Inc. (BMOD) - Product Pipeline Analysis
MDxHealth SA (ONCOB) - Product Pipeline Analysis
|
|
|
|
